Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplindore in Restless Legs Syndrome
NCT00626418Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aplindore in restless legs syndrome (RLS), sponsored by Ligand Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
aplindore
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00626418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626418.